Kymera Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 52.0M |
| FY2021 | 48.0M |
| FY2022 | 53.9M |
| FY2023 | 58.4M |
| FY2024 | 75.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 52.0M |
| FY2021 | 48.0M |
| FY2022 | 53.9M |
| FY2023 | 58.4M |
| FY2024 | 75.0M |